Trials / Completed
CompletedNCT00841776
Comparative Antimicrobial Efficacy of Two Topical Acne Therapies for the Treatment of Facial Acne
Comparative Antimicrobial Efficacy of Two Topical Acne Therapies for the Treatment of Moderate to Moderately Severe Facial Acne Vulgaris
- Status
- Completed
- Phase
- Phase 4
- Study type
- Interventional
- Enrollment
- 54 (actual)
- Sponsor
- Stiefel, a GSK Company · Industry
- Sex
- All
- Age
- 12 Years
- Healthy volunteers
- Not accepted
Summary
The purpose of the study is to determine the development of microbial resistance when using one of two topical acne therapies for the treatment of facial acne vulgaris.
Detailed description
To investigate the development of microbial resistance when using one of two topical acne therapies for the treatment of moderate to moderately severe facial acne vulgaris. Clinical efficacy and tolerability will be assessed.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | Duac | Clindamycon and benzoyl peroxide topical gel once a day for 12 weeks |
| DRUG | Ziana gel | Clindamycin and tretinoin gel once a day for 12 weeks. |
Timeline
- Start date
- 2007-08-01
- Primary completion
- 2008-11-01
- Completion
- 2009-01-01
- First posted
- 2009-02-11
- Last updated
- 2017-05-25
- Results posted
- 2010-07-23
Locations
2 sites across 1 country: United States
Source: ClinicalTrials.gov record NCT00841776. Inclusion in this directory is not an endorsement.